Granulocyte-macrophage colony-stimulating factor inhalation therapy for patients with idiopathic pulmonary alveolar proteinosis: a pilot study; and long-term treatment with aerosolized granulocyte-macrophage colony-stimulating factor: a case report
β Scribed by Ryushi TAZAWA; Koh NAKATA; Yoshikazu INOUE; Toshihiro NUKIWA
- Book ID
- 108964419
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 155 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1323-7799
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. Granulocyte-macrophage-colony stimulating factor (GM-CSF) administration stimulates the proliferation of hemopoietic progenitors. Shortly (48 -96 hours) after its discontinuation, feedback phenomena occur and the progenitor proliferation rate drops below baseline levels. As the quies
## BACKGROUND. Interleukin-2 (IL-2) and granulocyte-macrophageΟͺcolony stimulating factor (GM-CSF) are cytokines with nonoverlapping pleiotropic effects. In a prior Phase Ib study, this combination of agents exhibited antitumor effects in the lungs of four of eight patients with renal cell carcinoma